Article Text

Download PDFPDF

Fifteen-minute consultation: Initial management of suspected acute leukaemia by non-specialists
  1. Sam Behjati1,2,
  2. Amy Ruffle2,3,
  3. Anne Kelly2,
  4. Emmy Dickens2
  1. 1 Department of Paediatrics, University of Cambridge, Cambridge, UK
  2. 2 Department of Paediatric Oncology and Haematology, Addenbrooke’s Hospital, Cambridge, UK
  3. 3 Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
  1. Correspondence to Dr Sam Behjati, University of Cambridge, Cambridge CB2 1TN, UK; sam.behjati{at}gmail.com

Abstract

Leukaemia is the most common cancer of childhood. Most children with a new diagnosis of leukaemia are clinically stable at initial presentation. However, there are a number of life-threatening complications that have to be considered and monitored for. These complications include sepsis, tumour lysis syndrome, mediastinal masses, bleeding and pain. The aim of this article is to equip the general paediatrician with a framework for managing children with suspected leukaemia, prior to transfer to the primary treatment centre. The presentation, diagnosis and definitive treatment of acute leukaemia is not in the remit of this article.

  • oncology
  • leukaemia
  • children

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • SB and AR were joint first authors.

  • SB and AR contributed equally.

  • Contributors SB conceived of the paper. AR and SB were both co-authors on this paper. AR did the literature search. ED and AK contributed expert views. All authors have contributed to editing successive drafts and agreed the content of the final article.

  • Funding This study was funded by Wellcome Trust (Grant 110104/Z/15/Z).

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.